Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 62,708 | 0.1% | 81,242 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 55,576 | 0.1% | 98,843 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 55,242 | 0.1% | 105,222 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 61,754 | 0.2% | 97,368 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 99,696 | 0.3% | 139,958 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 146,910 | 0.4% | 139,749 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 152,257 | 0.5% | 144,865 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 74,718 | 0.3% | 77,630 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 57,932 | 0.2% | 65,960 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 53,828 | 0.2% | 65,408 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 45,254 | 0.2% | 62,981 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 49,292 | 0.2% | 59,990 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 29,736 | 0.2% | 41,215 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 23,417 | 0.1% | 33,993 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 19,773 | 0.1% | 33,449 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 28,924 | 0.1% | 41,413 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 21,693 | 0.1% | 34,350 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 30,473 | 0.2% | 50,353 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 33,840 | 0.2% | 60,587 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 24,818 | 0.1% | 52,454 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 22,370 | 0.1% | 46,304 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 21,077 | 0.1% | 37,653 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 20,473 | 0.2% | 32,828 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 18,614 | 0.2% | 38,120 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 7,558 | 0.1% | 20,128 | 12/31/2019 |
| 2014 Q2 | 8/6/2014 | 11,420 | 0.3% | 40,431 | 6/30/2014 |
| 2014 Q1 | 4/29/2014 | 9,819 | 0.3% | 32,700 | 3/31/2014 |
| 2013 Q4 | 2/3/2014 | 9,654 | 0.3% | 35,076 | 12/31/2013 |